KUMULUS VAPE (ALVAP.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:ALVAP • FR0013419876

3.88 EUR
0 (0%)
Last: Feb 10, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

Overall ALVAP gets a fundamental rating of 6 out of 10. We evaluated ALVAP against 59 industry peers in the Specialty Retail industry. While ALVAP has a great health rating, its profitability is only average at the moment. ALVAP has a valuation in line with the averages, but it does not seem to be growing. Finally ALVAP also has an excellent dividend rating. With these ratings, ALVAP could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • ALVAP had positive earnings in the past year.
  • ALVAP had a negative operating cash flow in the past year.
  • ALVAP had positive earnings in each of the past 5 years.
  • In the past 5 years ALVAP reported 4 times negative operating cash flow.
ALVAP.PA Yearly Net Income VS EBIT VS OCF VS FCFALVAP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

  • ALVAP's Return On Assets of 9.80% is amongst the best of the industry. ALVAP outperforms 86.44% of its industry peers.
  • Looking at the Return On Equity, with a value of 16.02%, ALVAP is in the better half of the industry, outperforming 76.27% of the companies in the same industry.
  • ALVAP has a better Return On Invested Capital (12.74%) than 83.05% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ALVAP is above the industry average of 9.72%.
Industry RankSector Rank
ROA 9.8%
ROE 16.02%
ROIC 12.74%
ROA(3y)9.89%
ROA(5y)10.27%
ROE(3y)16.02%
ROE(5y)15.99%
ROIC(3y)13.64%
ROIC(5y)14.38%
ALVAP.PA Yearly ROA, ROE, ROICALVAP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 4.35%, ALVAP is in the better half of the industry, outperforming 74.58% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ALVAP has grown nicely.
  • ALVAP has a better Operating Margin (5.89%) than 74.58% of its industry peers.
  • In the last couple of years the Operating Margin of ALVAP has grown nicely.
  • Looking at the Gross Margin, with a value of 23.53%, ALVAP is doing worse than 67.80% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ALVAP has remained more or less at the same level.
Industry RankSector Rank
OM 5.89%
PM (TTM) 4.35%
GM 23.53%
OM growth 3Y0.64%
OM growth 5Y19.19%
PM growth 3Y4.02%
PM growth 5Y42.75%
GM growth 3Y5.68%
GM growth 5Y0.12%
ALVAP.PA Yearly Profit, Operating, Gross MarginsALVAP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ALVAP is creating value.
  • The number of shares outstanding for ALVAP remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for ALVAP has been increased compared to 5 years ago.
  • The debt/assets ratio for ALVAP has been reduced compared to a year ago.
ALVAP.PA Yearly Shares OutstandingALVAP.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALVAP.PA Yearly Total Debt VS Total AssetsALVAP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • ALVAP has an Altman-Z score of 4.52. This indicates that ALVAP is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 4.52, ALVAP belongs to the best of the industry, outperforming 89.83% of the companies in the same industry.
  • ALVAP has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.21, ALVAP belongs to the top of the industry, outperforming 84.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 4.52
ROIC/WACC1.84
WACC6.93%
ALVAP.PA Yearly LT Debt VS Equity VS FCFALVAP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

  • ALVAP has a Current Ratio of 3.30. This indicates that ALVAP is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 3.30, ALVAP belongs to the top of the industry, outperforming 91.53% of the companies in the same industry.
  • ALVAP has a Quick Ratio of 1.76. This is a normal value and indicates that ALVAP is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of ALVAP (1.76) is better than 91.53% of its industry peers.
Industry RankSector Rank
Current Ratio 3.3
Quick Ratio 1.76
ALVAP.PA Yearly Current Assets VS Current LiabilitesALVAP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The earnings per share for ALVAP have decreased strongly by -21.52% in the last year.
  • ALVAP shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 97.48% yearly.
  • The Revenue for ALVAP has decreased by -34.12% in the past year. This is quite bad
  • The Revenue has been growing by 41.89% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-21.52%
EPS 3Y20.5%
EPS 5Y97.48%
EPS Q2Q%-23.21%
Revenue 1Y (TTM)-34.12%
Revenue growth 3Y20.74%
Revenue growth 5Y41.89%
Sales Q2Q%-51.16%

3.2 Future

  • Based on estimates for the next years, ALVAP will show a decrease in Earnings Per Share. The EPS will decrease by -1.02% on average per year.
  • The Revenue is expected to decrease by -0.11% on average over the next years.
EPS Next Y-34.55%
EPS Next 2Y-4.02%
EPS Next 3Y-1.02%
EPS Next 5YN/A
Revenue Next Year-6.25%
Revenue Next 2Y-0.99%
Revenue Next 3Y-0.11%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALVAP.PA Yearly Revenue VS EstimatesALVAP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ALVAP.PA Yearly EPS VS EstimatesALVAP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • ALVAP is valuated cheaply with a Price/Earnings ratio of 4.79.
  • Based on the Price/Earnings ratio, ALVAP is valued cheaply inside the industry as 98.31% of the companies are valued more expensively.
  • ALVAP is valuated cheaply when we compare the Price/Earnings ratio to 28.03, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 6.98, the valuation of ALVAP can be described as very cheap.
  • ALVAP's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALVAP is cheaper than 89.83% of the companies in the same industry.
  • ALVAP is valuated cheaply when we compare the Price/Forward Earnings ratio to 27.97, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 4.79
Fwd PE 6.98
ALVAP.PA Price Earnings VS Forward Price EarningsALVAP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 96.61% of the companies in the same industry are more expensive than ALVAP, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.5
ALVAP.PA Per share dataALVAP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • ALVAP has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.05
EPS Next 2Y-4.02%
EPS Next 3Y-1.02%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • ALVAP has a Yearly Dividend Yield of 4.52%, which is a nice return.
  • ALVAP's Dividend Yield is rather good when compared to the industry average which is at 1.31. ALVAP pays more dividend than 91.53% of the companies in the same industry.
  • ALVAP's Dividend Yield is rather good when compared to the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 4.52%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years2
ALVAP.PA Yearly Dividends per shareALVAP.PA Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

  • 17.40% of the earnings are spent on dividend by ALVAP. This is a low number and sustainable payout ratio.
DP17.4%
EPS Next 2Y-4.02%
EPS Next 3Y-1.02%
ALVAP.PA Yearly Income VS Free CF VS DividendALVAP.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 2M -2M 4M
ALVAP.PA Dividend Payout.ALVAP.PA Dividend Payout, showing the Payout Ratio.ALVAP.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

KUMULUS VAPE

EPA:ALVAP (2/10/2026, 7:00:00 PM)

3.88

0 (0%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners36.98%
Ins Owner ChangeN/A
Market Cap11.91M
Revenue(TTM)60.68M
Net Income(TTM)2.64M
Analysts86.67
Price Target7.04 (81.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.52%
Yearly Dividend0.15
Dividend Growth(5Y)N/A
DP17.4%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-4.17%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)25.58%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 4.79
Fwd PE 6.98
P/S 0.2
P/FCF N/A
P/OCF N/A
P/B 0.72
P/tB 0.89
EV/EBITDA 2.5
EPS(TTM)0.81
EY20.88%
EPS(NY)0.56
Fwd EY14.34%
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS19.77
BVpS5.37
TBVpS4.36
PEG (NY)N/A
PEG (5Y)0.05
Graham Number9.89
Profitability
Industry RankSector Rank
ROA 9.8%
ROE 16.02%
ROCE 17.82%
ROIC 12.74%
ROICexc 17.68%
ROICexgc 22.48%
OM 5.89%
PM (TTM) 4.35%
GM 23.53%
FCFM N/A
ROA(3y)9.89%
ROA(5y)10.27%
ROE(3y)16.02%
ROE(5y)15.99%
ROIC(3y)13.64%
ROIC(5y)14.38%
ROICexc(3y)17.75%
ROICexc(5y)21.73%
ROICexgc(3y)22.02%
ROICexgc(5y)24.77%
ROCE(3y)19.12%
ROCE(5y)20.26%
ROICexgc growth 3Y1.55%
ROICexgc growth 5Y9.12%
ROICexc growth 3Y-5.62%
ROICexc growth 5Y6.22%
OM growth 3Y0.64%
OM growth 5Y19.19%
PM growth 3Y4.02%
PM growth 5Y42.75%
GM growth 3Y5.68%
GM growth 5Y0.12%
F-Score3
Asset Turnover2.25
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA 0.82
Cap/Depr 57.64%
Cap/Sales 0.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.3
Quick Ratio 1.76
Altman-Z 4.52
F-Score3
WACC6.93%
ROIC/WACC1.84
Cap/Depr(3y)181.05%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.97%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.52%
EPS 3Y20.5%
EPS 5Y97.48%
EPS Q2Q%-23.21%
EPS Next Y-34.55%
EPS Next 2Y-4.02%
EPS Next 3Y-1.02%
EPS Next 5YN/A
Revenue 1Y (TTM)-34.12%
Revenue growth 3Y20.74%
Revenue growth 5Y41.89%
Sales Q2Q%-51.16%
Revenue Next Year-6.25%
Revenue Next 2Y-0.99%
Revenue Next 3Y-0.11%
Revenue Next 5YN/A
EBIT growth 1Y-24.22%
EBIT growth 3Y21.51%
EBIT growth 5Y69.12%
EBIT Next Year-5.88%
EBIT Next 3Y3.78%
EBIT Next 5YN/A
FCF growth 1Y-124.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-117.39%
OCF growth 3YN/A
OCF growth 5YN/A

KUMULUS VAPE / ALVAP.PA FAQ

What is the fundamental rating for ALVAP stock?

ChartMill assigns a fundamental rating of 6 / 10 to ALVAP.PA.


What is the valuation status of KUMULUS VAPE (ALVAP.PA) stock?

ChartMill assigns a valuation rating of 6 / 10 to KUMULUS VAPE (ALVAP.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for KUMULUS VAPE?

KUMULUS VAPE (ALVAP.PA) has a profitability rating of 6 / 10.


What are the PE and PB ratios of KUMULUS VAPE (ALVAP.PA) stock?

The Price/Earnings (PE) ratio for KUMULUS VAPE (ALVAP.PA) is 4.79 and the Price/Book (PB) ratio is 0.72.


Can you provide the financial health for ALVAP stock?

The financial health rating of KUMULUS VAPE (ALVAP.PA) is 7 / 10.